Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 10, 2010, Pages 4756-4761

  Kontak, Andrew C ^a   Wang, Zhongyun ^a   Arbique, Debbie ^a   Adams Huet, Beverley ^a   Auchus, Richard J ^a   Nesbitt, Shawna D ^a   Victor, Ronald G ^b   Vongpatanasin, Wanpen ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE;

ACTH SECRETING ADENOMA; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE;

ANIMALIA;

EID: 77957757456     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0823     Document Type: Article

References (37)

1. de Kloet ER, Van Acker SA, Sibug RM, Oitzl MS, Meijer OC, Rahmouni K, de Jong W 2000 Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int 57:1329-1336
2. Felder RB 2010 Mineralocorticoid receptors, inflammation and sympathetic drive in a rat model of systolic heart failure. Exp Physiol 95:19-25
3. Gomez-Sanchez EP 2010 The mammalian mineralocorticoid receptor: tying down a promiscuous receptor. Exp Physiol 95:13-18
4. Gomez-Sanchez EP 1986 Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 118:819-823
5. Francis J, Beltz T, Johnson AK, Felder RB 2003 Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-α in normal rats. Am J Physiol Regul Integr Comp Physiol 285:R1402-R1409
6. Wang H, Huang BS, Leenen FH 2003 Brain sodium channels and ouabainlike compounds mediate central aldosterone-induced hypertension. Am J Physiol Heart Circ Physiol 285:H2516-H2523
7. Kageyama Y, Bravo EL 1988 Hypertensive mechanisms associated with centrally administered aldosterone in dogs. Hypertension 11:750-753
8. Thomas GD, O'Hagan KP, Zambraski EJ 1991 Chemical sympathectomy alters the development of hypertension in miniature swine. Hypertension 17:357-362
9. Menon DV, Arbique D, Wang Z, Adams-Huet B, Auchus RJ, Vongpatanasin W 2009 Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients. J Clin Endocrinol Metab 94:1361-1366
10. Wray DW, Supiano MA 2010 Impact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatric hypertension. Hypertension 55:1217-1223
11. Miyajima E, Yamada Y, Yoshida Y, Matsukawa T, Shionoiri H, Tochikubo O, Ishii M 1991 Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 17:1057-1062
12. Matsukawa T, Miyamoto T 2008 Does infusion of ANG II increase muscle sympathetic nerve activity in patients with primary aldosteronism? Am J Physiol Regul Integr Comp Physiol 294:R1873-R1879
13. Victor RG, Haley RW, Willett DL, Peshock RM, Vaeth PC, Leonard D, Basit M, Cooper RS, Iannacchione VG, Visscher WA, Staab JM, Hobbs HH 2004 The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 93:1473-1480
14. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266-3281
15. Valbo AB, Hagbarth KE, Torebjörk HE, Wallin BG 1979 Somato-sensory proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev 59:919-957
16. Leimbach Jr WN, Wallin BG, Victor RG, Aylward PE, Sundlöf G, Mark AL 1986 Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73:913-919
17. Abate NI, Mansour YH, Tuncel M, Arbique D, Chavoshan B, Kizilbash A, Howell-Stampley T, Vongpatanasin W, Victor RG 2001 Overweight and sympathetic overactivity in Black Americans. Hypertension 38:379-383
18. Uhr M, Holsboer F, Müller MB 2002 Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J Neuroendocrinol 14:753-759
19. Yu Y, Wei SG, Zhang ZH, Gomez-Sanchez E, Weiss RM, Felder RB 2008 Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure? Hypertension 51:727-733
20. Gomez-Sanchez EP, Ahmad N, Romero DG, Gomez-Sanchez CE 2005 Is aldosterone synthesized within the rat brain? Am J Physiol Endocrinol Metab 288:E342-E346
21. Nwariaku FE, Miller BS, Auchus R, Holt S, Watumull L, Dolmatch B, Nesbitt S, Vongpatanasin W, Victor R, Wians F, Livingston E, Snyder 3rd WH 2006 Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg 141:497-502; discussion 502-503
22. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA 2004 Role for adrenal venous sampling in primary aldosteronism. Surgery 136:1227-1235
23. Simon DR, Palese MA 2008 Noninvasive adrenal imaging in hyperaldosteronism. Curr Urol Rep 9:80-87
24. Brown IJ, Tzoulaki I, Candeias V, Elliott P 2009 Salt intakes around the world: implications for public health. Int J Epidemiol 38:791-813
25. Michikawa T, Nishiwaki Y, Okamura T, Asakura K, Nakano M, Takebayashi T 2009 The taste of salt measured by a simple test and blood pressure in Japanese women and men. Hypertens Res 32:399-403
26. Jurgens G, Graudal NA 2004 Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database Syst Rev CD004022
27. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB 2001 Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 281:H2241-H2251
28. Felder RB 2010 Mineralocorticoid receptors, inflammation and sympathetic drive in heart failure. Exp Physiol 95:19-23
29. Geerling JC, Loewy AD 2009 Aldosterone in the brain. Am J Physiol Renal Physiol 297:F559-F576
30. Wang W, McClain JM, Zucker IH 1992 Aldosterone reduces baroreceptor discharge in the dog. Hypertension 19:270-277
31. Munakata M, Aihara A, Imai Y, Omata K, Abe K, Yoshinaga K 1995 Increased gain in baroreceptor-heart rate reflex in patients with primary aldosteronism. J Hypertens 13:1648-1653
32. Masuo K, Mikami H, Ogihara T, Tuck ML 1997 Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 10:77-83
33. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML 2003 Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42:474-480
34. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T 1984 Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819-823
35. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-1248
36. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA 2008 Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168:80-85
37. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello MJ, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Pessina AC, Mantero F 2006 Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 48:232-238